Ardelyx | Omløpsmidler



Current Assets Endring Dato
Abbott USD 23.66B 146M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Ardelyx USD 356.45M 72.35M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Life Technologies USD 81.95M 5.64M 2024-12
Sanofi 42.59B 12.51B 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12



Ardelyx Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.